0000950170-23-068288.txt : 20231205
0000950170-23-068288.hdr.sgml : 20231205
20231205172812
ACCESSION NUMBER: 0000950170-23-068288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231202
FILED AS OF DATE: 20231205
DATE AS OF CHANGE: 20231205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chee Conley
CENTRAL INDEX KEY: 0001883804
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37813
FILM NUMBER: 231467717
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 35 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001556263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453772460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-744-1340
MAIL ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: LS22, Inc.
DATE OF NAME CHANGE: 20120815
4
1
ownership.xml
4
X0508
4
2023-12-02
0001556263
Syros Pharmaceuticals, Inc.
SYRS
0001883804
Chee Conley
C/O SYROS PHARMACEUTICALS, INC.
35 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
true
true
false
false
President & CEO
false
Restricted Stock Units
2023-12-02
4
A
false
86000
0.00
A
Common Stock
86000
86000
D
Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
These RSUs will vest as to one third (1/3rd) of the shares underlying the award on December 31, 2024 and as to an additional one third (1/3rd) of such shares at the end of each successive year thereafter.
/s/ Todd Rosenthal, as attorney-in-fact
2023-12-05